Cytek Stock

cytekbio.comHealthcare / Other HealthcareFunding to Date: $81.75MM

Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services.

Register for Details

For more details on financing and valuation for Cytek, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cytek.

Register Today

Team

Management Team

Ming Yan Ph.D
Co-Founder, Chief Technology Officer & Board Member
Wenbin Jiang Ph.D
Co-Founder, Chief Executive Officer & Board Member
Eric Chase Ph.D
Chief Scientist & Board Member
Ken Riley
General Manager

Board Members

Kevin Yan
Xin Huang MD
Cowin Venture
Eric Chase Ph.D
Ming Yan Ph.D
Wenbin Jiang Ph.D

Other companies like Cytek in the Other Healthcare sector

Sector
Last Round Est. Valuation
$165MM
Sector
Last Round Est. Valuation
$368.08MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$125MM
Sector
Last Round Est. Valuation
$140MM
Sector
Last Round Est. Valuation
$300.91MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$173.59MM

News Highlights

In Brief This Week: Labcorp, Personal Genome Diagnostics, Applied DNA Sciences, Cytek, More
News items for the week of Feb. 21, 2022.
Piper Sandler Initiates Coverage of Cytek Biosciences With Overweight Rating
The investment bank said that Cytek was well positioned to remain one of the fastest growing life science tools companies, thanks to its light-based cell analysis technology.
Cytek Biosciences Adds Investors, Completes Series C Financing
Worldwide Success of Company’s Aurora Flow Cytometry Systems Accelerates Momentum
Updated on: Sep 23, 2023